Form 4: Resmed CEO Receives Stock Grant
Insider Transaction (Form 4)
Michael J. Farrell, Chairman and CEO and a Director of Resmed Inc, received 13,547 shares of common stock on August 14, 2026.
Summary
- Grant/award: acquired 13,547 ResMed Common Stock on August 14, 2026; holds 479,803 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Michael J. Farrell — Director, Officer (Chairman and CEO)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-14 | Grant/award | ResMed Common Stock | 13,547 | — | — | 479,803 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-14 | Grant/award (13,547 shares) |
Keywords
insider transaction, Form 4, RMD, RESMED INC, neutral, Michael J. Farrell
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.